Deleterious BRCA1 Gene Mutation
6 clinical trials · Condition
◉ Watch Deleterious BRCA1 Gene Mutation
| Record | Firm | Date |
|---|---|---|
| Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer (NCT03432676) | M.D. Anderson Cancer Center | 2019-07-31 |
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
| Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants (NCT03546972) | M.D. Anderson Cancer Center | 2017-12-17 |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations (NCT02760849) | M.D. Anderson Cancer Center | 2016-05-02 |
| Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer (NCT02282345) | M.D. Anderson Cancer Center | 2015-04-16 |
Track Deleterious BRCA1 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.